AMGN

AMGEN Inc

359.33

Jun 29 • 01:20PM ET +1.01 (0.28%)

Healthcare Drug Manufacturers - General USA Large NASD

Jun 26, 8:30 AMEuropean medicines regulators recommend revoking Amgen’s EU marketing authorization for its vasculitis drug Tavneos.

Peers: GILD LLY MRK ABBV PFE JNJ BMY REGN VRTX BIIB

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500
Market Cap	193.94B
Enterprise Value	239.22B
Income	7.80B
Sales	37.30B
Book/sh	17.03
Cash/sh	22.30
Dividend Est.	10.22 (2.85%)
Dividend TTM	9.80 (2.73%)
Dividend Ex-Date	May 15, 2026
Dividend Gr. 3/5Y	7.05% 8.27%
Payout	66.92%
Employees	31500
IPO	Jun 17, 1983

P/E	24.99
Forward P/E	15.35
PEG	4.18
P/S	5.20
P/B	21.10
P/C	16.11
P/FCF	22.56
EV/EBITDA	14.29
EV/Sales	6.41
Quick Ratio	1.01
Current Ratio	1.26
Debt/Eq	6.24
LT Debt/Eq	5.65
Option/Short	Yes / Yes

EPS (ttm)	14.38
EPS next Y	23.41
EPS next Q	5.60
EPS this Y	2.49%
EPS next Y	4.60%
EPS next 5Y	3.67%
EPS past 3/5Y	5.51% 2.93%
Sales past 3/5Y	12.09% 7.79%
EPS Y/Y TTM	31.14%
Sales Y/Y TTM	9.94%
EPS Q/Q	4.57%
Sales Q/Q	6.93%
Earnings	Apr 30 AMC
EPS/Sales Surpr.	8.04% 0.50%

Insider Own	0.23%
Insider Trans	-4.39%
Inst Own	83.16%
Inst Trans	-1.22%
ROA	8.58%
ROE	101.32%
ROIC	12.77%
Gross Margin	71.51%
Oper. Margin	31.75%
Profit Margin	20.91%
SMA20	3.86%
SMA50	5.55%
SMA200	7.58%
Trades

Shs Outstand	539.70M
Shs Float	538.48M
Short Float	2.27%
Short Ratio	4.39
Short Interest	12.20M
52W High	391.29 -8.17%
52W Low	269.77 33.20%
Volatility	2.13% 2.46%
ATR (14)	8.47
RSI (14)	62.54
Beta	0.39
Rel Volume	0.50
Avg Volume	2.78M
Volume	855,747

Perf Week	4.24%
Perf Month	6.79%
Perf Quarter	3.03%
Perf Half Y	7.60%
Perf YTD	9.78%
Perf Year	29.66%
Perf 3Y	62.48%
Perf 5Y	48.20%
Perf 10Y	139.40%
Recom	2.44
Target Price	352.35
Prev Close	358.33
Price	359.33
Change	0.28%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-26	Downgrade	Erste Group	Buy → Hold
Apr-21-26	Initiated	Canaccord Genuity	Hold	$366
Mar-10-26	Initiated	Jefferies	Hold	$350
Feb-20-26	Initiated	Barclays	Equal Weight	$185
Jan-20-26	Downgrade	Bernstein	Outperform → Mkt Perform	$335
Jan-07-26	Resumed	UBS	Buy	$380
Dec-05-25	Upgrade	Erste Group	Hold → Buy
Nov-24-25	Resumed	Truist	Hold	$318
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$385
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform

Show Previous Ratings

Jun-26-26 08:26AM	European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked (The Wall Street Journal)
Jun-25-26 02:20AM	FTSE 100 Live: Stocks hit record highs on both sides of pond (Proactive)
Jun-22-26 03:47PM	Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court (Yahoo Finance Video)
08:46AM	Dow Jones opens higher but Nasdaq flat as hawkish Fed still looms (Proactive)
Jun-18-26 08:56PM	How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story (Trefis)
04:57PM	Loading…
04:57PM	What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? (Trefis)
11:52AM	Here's what's weighing on the Dow today (MarketWatch)
Jun-17-26 02:21PM	Eli Lilly Stock's Trillion-Dollar Question (Trefis)
12:39PM	Vedana debuts with $46m to progress migraine therapies (Pharmaceutical Technology)
11:57AM	Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished (Trefis)
Jun-12-26 01:31PM	The Catch Hiding In Eli Lilly Stock's Growth Story (Trefis)
09:09AM	Amgen's $500 Million Tavneos Faces FDA Withdrawal Fight (GuruFocus.com)
Jun-11-26 03:24PM	Dow's gain builds, toward biggest point rise in two months (MarketWatch)
03:15PM	Dow up 889 points on gains for shares of Honeywell, Amgen (MarketWatch)
02:14PM	Dow's 750-point rally led by gains in shares of Amgen, Boeing (MarketWatch)
01:13PM	Loading…
01:13PM	Amgen, Honeywell share gains lead Dow's 265-point jump (MarketWatch)
12:12PM	Caterpillar, Amgen share gains lead Dow's 414-point jump (MarketWatch)
09:46AM	Dow rallies 288 points on gains for Amgen, Caterpillar shares (MarketWatch)
08:37AM	Nasdaq semis stocks lead rebound rally despite Trump warning of new Iran strikes (Proactive)
03:00AM	Takedas $4B TYK2 drug tops Bristol Myers Sotyktu in head-to-head test (BioPharma Dive)
Jun-09-26 01:29PM	All 30 Dow Jones Stocks Ranked: Buy, Sell or Hold? (Kiplinger)
Jun-08-26 03:49PM	Why Is Lilly Stock Growing Like A Silicon Valley Tech Darling? (Trefis)
09:07AM	Can MariTide Save Amgen Stock From Its Fading Blockbusters? (Trefis)
Jun-07-26 04:45PM	AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS (PR Newswire)
Jun-05-26 06:55PM	Is Amgen An Undervalued Stock Or Value Trap? (Trefis)
Jun-04-26 04:23PM	75% Upside For LLY Stock? (Trefis)
04:21PM	Quantinuum Shares Pare Gains to Close Little Changed After IPO (Bloomberg)
04:01PM	AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Jun-03-26 09:00AM	AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026 (PR Newswire)
Jun-02-26 11:28AM	ASCO 2026: Mixed SCLC result for Legends LB2102, Novartis expedites manufacture (Pharmaceutical Technology)
04:00PM	Loading…
Jun-01-26 04:00PM	EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER (PR Newswire)
07:17AM	MIT bullish on its Initiative for New Manufacturing at the one-year mark (Manufacturing Dive)
May-29-26 04:01PM	AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-27-26 12:00PM	A New, Powerful Cholesterol-Lowering Drug Is on the Horizon (The Wall Street Journal)
09:00AM	Ember LifeSciences announces new strategic investments boosting Series A to $27M (PR Newswire)
May-26-26 10:38AM	Honeywell-Backed Quantinuum Seeks $1.05 Billion in US IPO (Bloomberg)
07:56AM	Early data for heart drug affirm Lillys billion-dollar bet on Verve (BioPharma Dive)
May-22-26 04:49AM	CFOs On the Move: Week ending May 22 (CFO.com)
May-21-26 10:35AM	Amgens boomerang CFO reaps $12.5M in cash, retention bonuses (CFO Dive)
06:24AM	Amgen Drug Gets New Warnings in Japan After Patient Deaths (The Wall Street Journal)
May-19-26 04:05PM	AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH (PR Newswire)
May-18-26 06:49AM	Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug (BioPharma Dive)
May-13-26 05:00AM	Why the FDAs push for real-time clinical trials could favor Big Pharma (Pharma Voice)
May-12-26 01:29PM	Dow is surviving the tech slide on Tuesday, supported by strength in these names (MarketWatch)
08:30AM	Wall Street's Cardiac Bet: Where Diagnostics Meet the Money (PR Newswire)
May-07-26 04:01PM	AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-05-26 08:05AM	Can This Small Rival Take On Amgen's Eye Disease Blockbuster? (Investor's Business Daily)
08:04AM	Viridian data lift prospects for thyroid eye disease drug (BioPharma Dive)
05:09AM	Whats at stake in Amgens showdown with the FDA? (Pharma Voice)
May-04-26 10:53AM	Amgen invests $300M more in Puerto Rico biologics plant (Quartz)
10:53AM	Amgen is pouring another $300 million into its Puerto Rico drug factory (Quartz)
09:00AM	AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR (PR Newswire)
May-01-26 03:50PM	Amgen is the biggest drag on the Dow Friday (MarketWatch)
12:20PM	The Dow's Early Gains Slipped Away. The S&P 500 and Nasdaq are Still at Records. (Barrons.com)
08:00AM	Nasdaq leads the pack as Apple impresses, Amgen drags on Dow (Proactive)
08:00AM	Apple leads Nasdaq higher at open, Amgen drags on Dow (Proactive)
03:17AM	Amgen Inc (AMGN) Q1 2026 Earnings Call Highlights: Strong Product Sales Growth Amidst ... (GuruFocus.com)
Apr-30-26 04:19PM	Amgen Posts Higher First-Quarter Profit, Revenue (The Wall Street Journal)
04:10PM	Amgen: Q1 Earnings Snapshot (Associated Press)
04:06PM	Amgen's Numbers Are Out: It Gets To Keep Its Cholesterol Crown - For Now (Investor's Business Daily)
04:01PM	AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS (PR Newswire)
05:09AM	Apple headlines a bumper slate of earnings (MarketWatch)
04:05AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to decline as oil hits new four-year high on report of possible Iran military action; Alphabet shares jump as Meta falls (MarketWatch)
Apr-29-26 07:00PM	Apple earnings, March PCE, Q1 GDP, mortgage rates: What to Watch (Yahoo Finance Video)
07:21AM	FDA tests out real-time clinical trials; AbbVie closes in on a KRAS biotech (BioPharma Dive)
Apr-28-26 03:00PM	FDA is launching real-time monitoring of drug trials, with AstraZeneca and Amgen as first test cases (Quartz)
05:57AM	FDA claims Amgen drug data were manipulated; Erasca slides despite home run results (BioPharma Dive)
Apr-24-26 04:01PM	AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
11:00AM	Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims (Yahoo Finance Video)
06:46AM	Lilly tumbles on Foundayos shaky week; FDA to issue vouchers for psychedelics (BioPharma Dive)
Apr-22-26 04:00PM	AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER (PR Newswire)
Apr-21-26 10:07AM	The Dow is outpacing the other indexes due to strong earnings from UnitedHealth Group (MarketWatch)
Apr-17-26 07:53AM	OpenAI is launching a specialized AI model for drug discovery and life sciences research (Quartz)
Apr-10-26 05:28PM	This Startup's Psoriasis Drug Studies Have Lifted Its Stock (Barrons.com)
Apr-09-26 01:27PM	Eli Lilly's Foundayo Weight-Loss Pill Hits the Shelves. It's a Turning Point for the Stock. (Barrons.com)
02:58AM	We Picked Amgen Stock a Year Ago. Stick With the Emerging GLP-1 Play. (Barrons.com)
Apr-07-26 08:00PM	Is Amgen (AMGN) Outperforming Other Medical Stocks This Year? (Quartz)
05:47PM	The $190 Billion 'Diabesity' Market Is Set to Explode. Lilly and Novo Face These Stock Catalysts. (Barrons.com)
09:49AM	FTSE 100 Live: Defence stocks lead decline as Trump's Iran deadline looms (Proactive)
Apr-06-26 12:10PM	Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study. (Barrons.com)
10:54AM	Under-the-skin Tepezza comparable to infused version in key study, Amgen says (BioPharma Dive)
09:03AM	Amgen Unveils Upbeat Results For Tepezza After Rival Eye Disease Drug Disappoints (Investor's Business Daily)
09:00AM	AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE (PR Newswire)
Apr-01-26 04:07PM	Why 2026 Is Biotech's Comeback Year (Barrons.com)
07:30AM	Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy (Business Wire)
Mar-31-26 11:16AM	FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths (The Wall Street Journal)
06:48AM	Viridian tumbles on positive data for key eye drug prospect (BioPharma Dive)
Mar-28-26 04:45PM	REPATHA CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS (PR Newswire)
Mar-18-26 10:00AM	Dow Jones leads Wall Street lower as oil prices spike on Iran threats, Fed awaited (Proactive)
06:11AM	Crossbow raises $77M for new cancer immunotherapies (BioPharma Dive)
Mar-16-26 10:10AM	Grail CEO Bob Ragusa to retire (MedTech Dive)
Mar-13-26 11:00AM	Starbucks, Amgen, and CVS Help This Income Fund Shine (Barrons.com)
Mar-12-26 03:04PM	Rapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ... (GuruFocus.com)
12:52PM	Rapid Micro Biosystems, Inc. Q4 2025 Earnings Call Summary (Moby)
12:30AM	GE Aerospace invest $115M in region (Cincinnati.com \| The Enquirer)
Mar-11-26 01:51PM	Biogen Stock: Is BIIB Outperforming the Healthcare Sector? (Barchart)
Mar-10-26 10:38AM	Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained (24/7 Wall St.)
08:06AM	Here Are Tuesday's Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's,Qualcomm, Rivian, Strategy and More (24/7 Wall St.)
Mar-09-26 12:02PM	BMY Wins FDA Nod to Expand Sotyktu Label for Psoriatic Arthritis (Zacks)
09:00AM	Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus (Zacks)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Chairman & CEOMr. Robert A. Bradway

Executive VP & CFOMr. Peter H. Griffith

Executive VP & CTODr. David M. Reese M.D.

EVP of Global Markets & PolicyMr. Murdo Gordon

EVP of Research & DevelopmentDr. James E. Bradner M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	May 04 '26	Sale	323.73	1,237	400,451	7,009	May 05 08:09 PM
Grygiel Nancy A.	Officer	May 04 '26	Proposed Sale	323.73	1,237	400,450		May 04 04:05 PM
Bradway Robert A	Chairman, CEO and President	Mar 04 '26	Option Exercise	156.35	119,782	18,727,916	576,928	Mar 06 07:32 PM
Santos Esteban	EVP, Operations	Feb 26 '26	Option Exercise	169.19	54,792	9,270,143	107,119	Mar 02 07:20 PM
Santos Esteban	EVP, Operations	Feb 26 '26	Sale	379.12	54,792	20,772,595	76,618	Mar 02 07:20 PM
Santos Esteban	Associate	Feb 26 '26	Proposed Sale	379.12	54,792	20,772,598		Feb 27 12:20 PM
Busch Matthew C.	VP, Finance & CAO	Feb 19 '26	Sale	375.79	1,000	375,790	3,423	Feb 20 07:43 PM
Busch Matthew C.	ASSOCIATED TO AFFILIATE	Feb 19 '26	Proposed Sale	375.00	1,000	375,000		Feb 19 03:55 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Option Exercise	169.70	3,139	532,691	8,864	Nov 21 08:34 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Sale	337.26	3,139	1,058,667	7,225	Nov 21 08:34 PM
Grygiel Nancy A.	Officer	Nov 20 '25	Proposed Sale	337.26	3,139	1,058,667		Nov 20 04:45 PM
Khosla Rachna	SVP, Business Development	Nov 12 '25	Sale	336.24	890	299,256	7,082	Nov 13 07:29 PM
Gordon Murdo	EVP, Global Commercial Ops	Nov 12 '25	Sale	336.83	6,879	2,317,071	41,923	Nov 13 07:28 PM
Gordon Murdo	Officer	Nov 12 '25	Proposed Sale	337.23	6,879	2,319,805		Nov 12 03:02 PM
Khosla Rachna	Officer	Nov 12 '25	Proposed Sale	337.42	890	300,304		Nov 12 02:50 PM
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

AMGN

AMGEN Inc

Upgrade your Finviz experience